TASMAR

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Croatia, Cyprus, Estonia, France, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, South Africa, Spain, Turkey, UK.

Active ingredients

The drug TASMAR contains one active pharmaceutical ingredient (API):

1	Tolcapone UNII CIF6334OLY - TOLCAPONE
	Tolcapone is an orally active, selective and reversible catechol-O-methyltransferase (COMT) inhibitor. Administered concomitantly with levodopa and an aromatic amino acid decarboxylase inhibitor (AADC-I), it leads to more stable plasma levels of levodopa by reducing metabolism of levodopa to 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD). High levels of plasma 3-OMD have been associated with poor response to levodopa in Parkinson’s disease patients.
	Read more about Tolcapone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TASMAR Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N04BX01	Tolcapone	N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BX Other dopaminergic agents
Discover more medicines within N04BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	512003001119311
EE	Ravimiamet	1196928, 1196939, 1196940, 1196951, 1196962, 1196973, 1598496
ES	Centro de información online de medicamentos de la AEMPS	97044003
FR	Base de données publique des médicaments	67077388
GB	Medicines & Healthcare Products Regulatory Agency	90611
IE	Health Products Regulatory Authority	49675
IT	Agenzia del Farmaco	033280025, 033280037, 033280049, 033280064, 033280076, 033280088, 033280090, 033280102, 033280114
LT	Valstybinė vaistų kontrolės tarnyba	1031010, 1031011, 1031012, 1031013, 1031014, 1031015, 1031016, 1031017, 1081084
NL	Z-Index G-Standaard, PRK	80179
NZ	Medicines and Medical Devices Safety Authority	7360
PL	Rejestru Produktów Leczniczych	100083537, 100085097
TR	İlaç ve Tıbbi Cihaz Kurumu	8698856090010
US	FDA, National Drug Code	0187-0938
ZA	Health Products Regulatory Authority	31/5.4.1/0396